Commentary: Directors of top cancer centers shouldn't take money from drug companies
by H. Gilbert Welch And David Carr, Los Angeles Times
Aug 07, 2019
3 minutes
Academic cancer centers are exalted for producing cutting-edge research and providing superior cancer care. Doctors and the public look to them for unbiased evidence on which cancer treatments lead to meaningful improvements in survival and quality of life - and which do not. Cancer center patients expect treatment recommendations that are driven solely by this science.
But there's a lot of money in cancer, and that means other influences can come into play. Cancer therapeutics
You’re reading a preview, subscribe to read more.
Start your free 30 days